1-4 of 4
Paul E. Monahan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy

Clinical Trials & Observations
Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan U. Lattimore, Frank W. G. Leebeek, Wolfgang A. Miesbach, Michael Recht, Robert Gut, Ricardo Dolmetsch, Paul E. Monahan, Sandra Le Quellec, Steven W. Pipe
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5671–5679.
https://doi.org/10.1182/bloodadvances.2022008886
Published: 2023
Includes: Supplemental data
Journal Articles

Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B

Clinical Trials & Observations
Manfred Schmidt, Graham R. Foster, Michiel Coppens, Hauke Thomsen, Ricardo Dolmetsch, Liesbeth Heijink, Paul E. Monahan, Steven W. Pipe
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4966–4969.
https://doi.org/10.1182/bloodadvances.2023009876
Published: 2023
Includes: Supplemental data
Journal Articles

Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity

Jocelyn A. Schroeder, Juan Chen, Yingyu Chen, Yuanhua Cai, Hongyin Yu, Jeremy G. Mattson, Paul E. Monahan, Qizhen Shi
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1224–1238.
https://doi.org/10.1182/bloodadvances.2020004071
Published: 2021
Includes: Supplemental data
Journal Articles

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B

Clinical Trials & Observations
J. Michael Soucie, Paul E. Monahan, Roshni Kulkarni, Barbara A. Konkle, Marshall A. Mazepa
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2136–2144.
https://doi.org/10.1182/bloodadvances.2018020552
Published: 2018